We are live on ! Find out more
NXTC icon

NextCure
NXTC

47 hedge funds and large institutions have $36M invested in NextCure in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

134% more capital invested

Capital invested by funds: $15.4M → $36M (+$20.6M)

9% more funds holding

Funds holding: 43 → 47 (+4)

0.81% more ownership

Funds ownership: 4.01% → 4.82% (+0.81%)

25% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 12

Holders
47
Holders Change
+4
Holders Change %
+9.3%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
12
Closed
2
Calls
$23K
Puts
–
Net Calls
+$23K
Net Calls Change
+$23K

Top Buyers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
+$2.76M
2
AAA
Affinity Asset Advisors
New York
+$1.95M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$613K
4
SSA
Schonfeld Strategic Advisors
New York
+$564K
5
CPA
Cardiff Park Advisors
California
+$376K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$2.25M
2
TCM
Tang Capital Management
California
-$464K
3
Citadel Advisors
Citadel Advisors
Florida
-$187K
4
BlackRock
BlackRock
New York
-$185K
5
AI
Acuitas Investments
Washington
-$73.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
SI
1
Sofinnova Investments
California
$5.96M – – –
LGM
2
Logos Global Management
California
$4.29M +$2.76M +160,417 New
AAA
3
Affinity Asset Advisors
New York
$3.03M +$1.95M +113,253 New
O
4
OrbiMed
New York
$2.54M -$2.25M -130,818 -58%
Millennium Management
5
Millennium Management
New York
$2.53M -$9.04K -525 -0.6%
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.2M +$120K +6,975 +9%
BlackRock
7
BlackRock
New York
$1.7M -$185K -10,730 -14%
CCC
8
Cable Car Capital
California
$1.37M – – –
LFCM
9
Long Focus Capital Management
Puerto Rico
$1.24M – – –
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$1.09M – – –
Assenagon Asset Management
11
Assenagon Asset Management
Luxembourg
$952K +$613K +35,560 New
Morgan Stanley
12
Morgan Stanley
New York
$897K +$345K +20,051 +149%
Renaissance Technologies
13
Renaissance Technologies
New York
$893K +$154K +8,924 +37%
SSA
14
Schonfeld Strategic Advisors
New York
$877K +$564K +32,770 New
Federated Hermes
15
Federated Hermes
Pennsylvania
$730K -$637 -37 -0.1%
AI
16
Acuitas Investments
Washington
$717K -$73.4K -4,262 -14%
BCM
17
BML Capital Management
Indiana
$683K – – –
CPA
18
Cardiff Park Advisors
California
$584K +$376K +21,833 New
Citadel Advisors
19
Citadel Advisors
Florida
$547K -$187K -10,865 -35%
Hudson Bay Capital Management
20
Hudson Bay Capital Management
Connecticut
$454K +$293K +16,983 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$390K – – –
Macquarie Group
22
Macquarie Group
Australia
$335K – – –
TCM
23
Tang Capital Management
California
$322K -$464K -26,951 -69%
SCM
24
Sio Capital Management
New York
$290K – – –
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$191K – – –
1
2

NXTC Hedge Fund Activity: Q1 2024 in Review

47 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q1 2024, worth a combined $36M — up 134% from $15.4M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NXTC positions and 2 closed out — a net gain of 4 holders — while 9 added to existing stakes and 12 trimmed.

The largest buyer was Logos Global Management, opening a new position worth an estimated $2.76M. The largest seller was OrbiMed, cutting an estimated $2.25M.

  • 47 institutional investors held NextCure (NXTC) as of Q1 2024, up from 43 in Q4 2023.
  • Funds reported $36M of NextCure stock for Q1 2024, up 134% quarter-over-quarter.
  • 6 funds opened new NextCure positions in Q1 2024 and 2 closed out, a net change of +4 holders.
  • The largest NextCure buyer in Q1 2024 was Logos Global Management, an estimated $2.76M added.
  • The largest NextCure seller in Q1 2024 was OrbiMed, an estimated $2.25M sold.

Based on aggregated 13F filings for Q1 2024.